Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) EVP Nathan Brower sold 12,015 shares of the firm’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $21.84, for a total value of $262,407.60. Following the transaction, the executive vice president directly owned 43,438 shares of the company’s stock, valued at $948,685.92. This represents a 21.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Nature’s Sunshine Products Trading Down 0.0%
Shares of Nature’s Sunshine Products stock opened at $21.85 on Friday. The firm has a market capitalization of $384.23 million, a P/E ratio of 19.86 and a beta of 0.95. The business has a fifty day simple moving average of $24.74 and a two-hundred day simple moving average of $23.55. Nature’s Sunshine Products, Inc. has a 12 month low of $12.97 and a 12 month high of $28.14.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.20 by $0.10. The business had revenue of $122.89 million during the quarter, compared to analyst estimates of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.
Hedge Funds Weigh In On Nature’s Sunshine Products
Analyst Ratings Changes
Several brokerages have commented on NATR. DA Davidson reissued a “buy” rating and set a $33.00 price objective on shares of Nature’s Sunshine Products in a research report on Monday, May 11th. Canaccord Genuity Group set a $37.00 price objective on Nature’s Sunshine Products in a research report on Friday, May 8th. Finally, Weiss Ratings raised Nature’s Sunshine Products from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $35.00.
Check Out Our Latest Analysis on NATR
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
See Also
- Five stocks we like better than Nature’s Sunshine Products
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
